These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27858056)

  • 1. Determinants of parasite drug resistance in human lymphatic filariasis.
    Cobo F
    Rev Esp Quimioter; 2016 Dec; 29(6):288-295. PubMed ID: 27858056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of lymphatic filariasis: do we have the drugs to complete the job?
    Bockarie MJ; Deb RM
    Curr Opin Infect Dis; 2010 Dec; 23(6):617-20. PubMed ID: 20847694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imported bancroftian filariasis: diethylcarbamazine response and benzimidazole susceptibility of Wuchereria bancrofti in dynamic cross-border migrant population targeted by the National Program to Eliminate Lymphatic Filariasis in South Thailand.
    Bhumiratana A; Pechgit P; Koyadun S; Siriaut C; Yongyuth P
    Acta Trop; 2010 Feb; 113(2):121-8. PubMed ID: 19835831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of albendazole for lymphatic filariasis.
    Horton J
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S33-40. PubMed ID: 19843396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of benzimidazole resistance-associated mutations in the filarial nematode Wuchereria bancrofti and evidence for selection by albendazole and ivermectin combination treatment.
    Schwab AE; Boakye DA; Kyelem D; Prichard RK
    Am J Trop Med Hyg; 2005 Aug; 73(2):234-8. PubMed ID: 16103581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albendazole for lymphatic filariasis.
    Addiss D; Critchley J; Ejere H; Garner P; Gelband H; Gamble C;
    Cochrane Database Syst Rev; 2004; (1):CD003753. PubMed ID: 14974034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albendazole for lymphatic filariasis.
    Critchley J; Addiss D; Gamble C; Garner P; Gelband H; Ejere H;
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003753. PubMed ID: 16235339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
    Kroidl I; Saathof E; Maganga L; Clowes P; Maboko L; Hoerauf A; Makunde WH; Haule A; Mviombo P; Pitter B; Mgeni N; Mabuye J; Kowuor D; Mwingira U; Malecela MN; Löscher T; Hoelscher M
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004618. PubMed ID: 27070786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An allele specific PCR assay for screening for drug resistance among Wuchereria bancrofti populations in India.
    Hoti SL; Dhamodharan R; Subramaniyan K; Das PK
    Indian J Med Res; 2009 Aug; 130(2):193-9. PubMed ID: 19797818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the chemotherapy of lymphatic filariasis.
    Navaratnam V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 2():51-4. PubMed ID: 7973948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass drug treatment for lymphatic filariasis and onchocerciasis.
    Molyneux DH; Bradley M; Hoerauf A; Kyelem D; Taylor MJ
    Trends Parasitol; 2003 Nov; 19(11):516-22. PubMed ID: 14580963
    [No Abstract]   [Full Text] [Related]  

  • 12. A triple-drug treatment regimen to accelerate elimination of lymphatic filariasis: From conception to delivery.
    Weil GJ; Jacobson JA; King JD
    Int Health; 2020 Dec; 13(Suppl 1):S60-S64. PubMed ID: 33349879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
    Hooper PJ; Bradley MH; Biswas G; Ottesen EA
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S17-21. PubMed ID: 19843394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection.
    Khan AM
    Indian J Med Res; 2018 Jan; 147(1):7-10. PubMed ID: 29749354
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphatic filariasis and Brugia timori: prospects for elimination.
    Fischer P; Supali T; Maizels RM
    Trends Parasitol; 2004 Aug; 20(8):351-5. PubMed ID: 15246315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis.
    Wkly Epidemiol Rec; 2004 Oct; 79(40):358-65. PubMed ID: 15631012
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence for the use of albendazole for the elimination of lymphatic filariasis.
    Sunish IP; Rajendran R; Mani TR; Dash AP; Tyagi BK
    Lancet Infect Dis; 2006 Mar; 6(3):125-6. PubMed ID: 16500593
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphatic filariasis and onchocerciasis.
    Taylor MJ; Hoerauf A; Bockarie M
    Lancet; 2010 Oct; 376(9747):1175-85. PubMed ID: 20739055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis.
    Gustavsen KM; Bradley MH; Wright AL
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S11-5. PubMed ID: 19843393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifilarial drugs, in the doses employed in mass drug administrations by the Global Programme to Eliminate Lymphatic Filariasis, reverse lymphatic pathology in children with Brugia malayi infection.
    Shenoy RK; Suma TK; Kumaraswami V; Rahmah N; Dhananjayan G; Padma S
    Ann Trop Med Parasitol; 2009 Apr; 103(3):235-47. PubMed ID: 19341538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.